| 000 | 01070 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250516081444.0 | ||
| 264 | 0 | _c20130204 | |
| 008 | 201302s 0 0 eng d | ||
| 022 | _a1432-1041 | ||
| 024 | 7 |
_a10.1007/s00228-012-1246-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSormani, Maria Pia | |
| 245 | 0 | 0 |
_aIndirect comparisons of treatment effects in multiple sclerosis. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _cAug 2012 |
||
| 300 |
_a1227-8; author reply 1225-6 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 |
_aPropylene Glycols _xtherapeutic use |
| 650 | 0 | 4 |
_aSphingosine _xanalogs & derivatives |
| 700 | 1 | _aSignori, Alessio | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 68 _gno. 8 _gp. 1227-8; author reply 1225-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00228-012-1246-1 _zAvailable from publisher's website |
| 999 |
_c21582866 _d21582866 |
||